查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2041729

皮膚毒性測試市場預測至2034年—按類型、測試方法、測試類別、最終用戶和地區分類的全球分析

Dermal Toxicity Testing Market Forecasts to 2034 - Global Analysis By Type (Product, Services and Other Types), Testing Method (In-vitro Testing, In-silico Modeling and In-vivo testing), Test Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球皮膚毒性​​測試市場規模將達到 30 億美元，並在預測期內以 10.3% 的複合年成長率成長，到 2034 年將達到 67 億美元。

經皮毒性試驗是一種科學方法，用於評估化學物質與皮膚接觸後可能產生的不良反應。這種試驗對於評估各種產品（包括化妝品、藥品和工業化學品）的安全性至關重要。經皮毒性試驗評估的參數包括皮膚外觀、紅斑（發紅）、水腫（腫脹）和其他刺激症狀。

據癌症研究所稱，正在研發的活性成分數量增加了90%以上，2019年達到3876種。目前，正在考慮使用囓齒動物進行長期致癌性研究，以評估藥物對人類的致癌性。

擴大研發活動

研發活動的拓展凸顯了新產品和新配方開發在將創新且安全的產品推向市場方面所發揮的關鍵作用。全面的皮膚毒性測試對於評估這些新產品的安全性至關重要。此外，為了遵守不斷變化的監管標準、保護公眾健康並建立消費者對新產品安全性的信心，對皮膚毒性測試服務的需求也不斷成長。

高成本

皮膚毒性測試需要專門的設施和設備，以確保結果的準確性和可靠性。維護這些設施、安裝和維護測試設備以及聘用熟練人員的成本可能相當高昂。需要測試的物質的複雜性和多樣性也會增加這些成本。此外，監管要求的變化可能需要進行額外的測試並更新調查方法，導致合規成本增加並阻礙市場擴張。

消費者意識不斷增強

隨著消費者對皮膚健康和安全的意識不斷增強，他們開始仔細查看產品標籤，並要求製造商提高透明度。消費者越來越意識到接觸個人保健產品、化妝品和藥品中某些化學物質可能帶來的風險。此外，這種對安全的重視也符合消費者對健康和環境永續性產品的更廣泛需求，從而推動了市場成長。

缺乏標準化

由於缺乏標準化的規程和指南，準確進行風險評估和解讀不同實驗室及研究的測試結果變得困難。此外，建立用於判定與經皮接觸相關的物質安全性的統一標準也面臨挑戰。更重要的是，這種缺乏協調導致監管機構和相關人員的效率低下和成本增加，阻礙了市場擴張。

新冠疫情的感染疾病

新冠疫情對經皮毒性測試市場造成了多方面的負面影響。該市場嚴重依賴製藥、化妝品和化學工業，而這些行業在經皮期間都受到衝擊。實驗室關閉、設施准入受限以及員工流動受限阻礙了經皮毒性測試的順利開展，進而影響了產品核准和上市計劃。此外，景氣衰退也導致一些公司重新評估其在非必要測試服務方面的投資，從而影響了整體市場成長。

在預測期內，In Silico模擬領域預計將佔據最大佔有率。

In Silico模擬領域預計將佔據最大的市場佔有率，因為它旨在透過模擬分子間相互作用、吸收速率以及對皮膚的潛在不良反應，來準確預測皮膚毒性。這些模型有助於減少動物試驗，符合倫理考量和監管要求，從而最大限度地減少試驗程序中動物的使用。此外，機器學習和人工智慧等技術的進步提高了In Silico模型的準確性和可靠性，使其成為毒性評估中不可或缺的工具，並推動了該領域的成長。

預計在預測期內，皮膚腐蝕測試領域將呈現最高的複合年成長率。

預計在預測期內，皮膚腐蝕測試領域將呈現最高的複合年成長率。皮膚腐蝕是指嚴重的皮膚損傷，其特徵是皮膚組織破壞和化學燒燙傷。這些測試通常包括將測試物質塗抹在實驗動物或體外模型的皮膚上，並觀察皮膚損傷的程度。此外，測試結果有助於將物質分類為腐蝕性或非腐蝕性，為產品安全評估提供重要數據，並指南監管決策和安全評估。這正在推動該領域的成長。

市佔率最大的地區：

在預測期內，亞太地區佔據了最大的市場佔有率，這主要得益於工業成長、監管環境改善以及消費者產品安全意識不斷提高等動態因素。該地區涵蓋中國、日本、印度和韓國等多元化經濟體，這些經濟體透過完善的毒性測試方案，為確保產品安全做出了貢獻。此外，消費者對個人保健產品和藥品的日益關注，也進一步推動了該地區對全面皮膚毒性測試的需求。

複合年成長率最高的地區：

預計在預測期內，歐洲將錄得最高的複合年成長率，這主要得益於對消費者安全的高度重視以及對尖端調查方法（尤其是體外和電腦模型等替代方法）的顯著應用。查爾斯河實驗室國際公司、Mattec公司、Intertek集團和GE醫療等領導企業正致力於提高經皮毒性評估的準確性和效率。此外，美國環保署（EPA）和食品藥物管理局（FDA）等機構制定的嚴格監管標準凸顯了全面毒性測試的重要性，這也推動了該地區市場的發展。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球皮膚毒性​​測試市場：按類型分類

  • 產品
  • 服務
    • 內部服務
    • 外包服務
  • 其他類型

第6章：全球皮膚毒性​​測試市場：依測試方法分類

  • 體外試驗
  • In Silico模擬
  • 體內試驗

第7章 全球皮膚毒性​​測試市場：依測試類型分類

  • 光毒性試驗
  • 皮膚刺激性測試
  • 皮膚致敏性測試
  • 皮膚腐蝕試驗
  • 其他測試類型

第8章 全球皮膚毒性​​測試市場：依最終用戶分類

  • 化妝品和個人保健產品行業
  • 化工
  • 醫療保健產業
  • 其他最終用戶

第9章 全球皮膚毒性​​測試市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第10章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章：公司簡介

  • SGS SA
  • Bio-Rad Laboratories Inc.
  • Charles River Laboratories International, Inc.
  • Catalent, Inc.
  • Eurofins Scientific Inc
  • Thermo Fisher Scientific, Inc.
  • Covance, Inc
  • GE Healthcare
  • Qiagen NV
  • Merck KgaA
  • Intertek Group
  • MatTek Corporation
  • Evotec
Product Code: SMRC24792

According to Stratistics MRC, the Global Dermal Toxicity Testing Market is accounted for $3.0 billion in 2026 and is expected to reach $6.7 billion by 2034 growing at a CAGR of 10.3% during the forecast period. Dermal toxicity testing is a scientific method employed to assess the potential harmful effects of chemical substances when they come into contact with the skin. This type of testing is crucial for evaluating the safety of various products, including cosmetics, pharmaceuticals, and industrial chemicals. Various parameters are assessed during dermal toxicity testing, such as skin appearance, erythema (redness), edema (swelling), and other signs of irritation.

According to the Cancer Research Institute, the number of active drugs in development grew by more than 90%, to 3,876 in 2019. Long-term rodent carcinogenicity studies for assessing the carcinogenic potential of drugs in humans are currently being examined.

Market Dynamics:

Driver:

Increasing research and development activities

The growth in R&D activities underscores the pivotal role of the development of new products and formulations to introduce innovative and safe products to the market. Comprehensive dermal toxicity testing becomes imperative to assess the safety profile of these advancements. Further, by the need to align with evolving regulatory standards, safeguard public health, and instill consumer confidence in the safety of newly developed products, the demand for dermal toxicity testing services is propelled.

Restraint:

High cost

Dermal toxicity testing requires specialized facilities and equipment to ensure accurate and reliable results. The costs of maintaining such facilities, acquiring and maintaining testing equipment, and employing skilled personnel can be significant. The complexity and diversity of substances that require testing further contribute to the costs. Furthermore, as regulatory requirements evolve, additional tests or updated methodologies may be necessary, leading to increased costs for compliance, which is hampering this market expansion.

Opportunity:

Rising consumer awareness

Rising awareness regarding skin health and safety prompts consumers to scrutinize product labels and demand transparency from manufacturers. Consumers are becoming more conscious of the potential risks associated with exposure to certain chemicals present in personal care products, cosmetics, and pharmaceuticals. Additionally, this emphasis on safety aligns with the broader trend of consumers seeking products that prioritize health and environmental sustainability, which are driving this market size.

Threat:

Limited standardization

The absence of standardized protocols and guidelines made it challenging to make accurate risk assessments and interpret test results obtained from different laboratories or studies. It also made it difficult to establish consistent criteria for determining the safety of substances in relation to dermal exposure. Moreover, the lack of harmonization resulted in inefficiencies and increased costs for both regulators and industry stakeholders, which are hindering this market expansion.

Covid-19 Impact

The COVID-19 pandemic has had several negative impacts on the dermal toxicity testing market. The dermal toxicity testing market relies heavily on the pharmaceutical, cosmetic, and chemical sectors, all of which experienced disruptions during the pandemic. Laboratory closures, restricted access to facilities, and limitations on workforce mobility impeded the smooth conduct of dermal toxicity tests, affecting timelines for product approvals and introductions. Furthermore, the economic downturn has prompted some businesses to reconsider their investments in non-essential testing services, affecting overall market growth.

The in-silico modeling segment is expected to be the largest during the forecast period

The in-silico modeling segment is estimated to hold the largest share, due to they aim to provide accurate predictions of dermal toxicity by simulating molecular interactions, absorption rates, and potential adverse effects on the skin. These models contribute to the reduction of animal testing, aligning with ethical considerations and regulatory efforts to minimize animal use in testing procedures. In addition, advancements in technology, such as machine learning and artificial intelligence, enhance the accuracy and reliability of in-silico models, making them valuable tools in toxicology assessments which are driving this segment's growth.

The skin corrosion tests segment is expected to have the highest CAGR during the forecast period

The skin corrosion tests segment is anticipated to have highest CAGR during the forecast period. It refers to severe damage to the skin, often characterized by the destruction of skin tissue, leading to chemical burns. These tests typically involve the application of the test substance to the skin of experimental animals or in vitro models, and observations are made to determine the extent of skin damage. Furthermore, the results help classify substances as corrosive or non-corrosive, guiding regulatory decisions and safety assessments by providing essential data for product safety assessments, which is boosting this segment expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to a dynamic landscape influenced by factors such as industrial growth, regulatory developments, and increasing awareness of product safety. The region encompasses diverse economies, including China, Japan, India, South Korea, and others, contributing to ensuring the safety of products through robust toxicity testing protocols. Moreover, increased awareness among consumers regarding personal care and pharmaceutical products further propels the demand for comprehensive dermal toxicity testing in this region.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to a strong focus on consumer safety and cutting-edge testing methodologies, with a notable shift towards alternative methods such as in vitro and in silico models. Key players such as Charles River Laboratories International, MatTek Corporation, Intertek Group, and GE Healthcare contribute to the accuracy and efficiency of dermal toxicity assessments. Further, stringent regulatory standards set by agencies like the U.S. Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) emphasize the importance of comprehensive toxicity testing, thereby driving this region.

Key players in the market

Some of the key players in the Dermal Toxicity Testing Market include SGS S.A, Bio-Rad Laboratories Inc., Charles River Laboratories International, Inc., Catalent, Inc., Eurofins Scientific Inc, Thermo Fisher Scientific, Inc., Covance, Inc , GE Healthcare, Qiagen N.V., Merck KgaA, Intertek Group, MatTek Corporation and Evotec.

Key Developments:

In December 2023, GE HealthCare and Nantworks AirStrip announced an agreement to Commercialize Integrated Patient Monitoring and Cardiac Data Visualization for Healthcare Systems.

In December 2023, SGS is pleased to announce the signing of an agreement to divest its crop science operations in 14 countries to Eurofins Scientific.

In November 2023, GE HealthCare (Nasdaq: GEHC) and Masimo announced a joint agreement to integrate Masimo Signal Extraction Technology (SET) pulse oximetry into GE HealthCare's Portrait Mobile wireless and wearable patient monitoring solution.

In October 2023, SGS is pleased to have signed an agreement to divest its US powertrain testing operations as part of its strategic portfolio evolution to Columbia River Partners, a private equity firm focused on the industrials, business services and IT services sectors.

Types Covered:

  • Product
  • Services
  • Other Types

Testing Methods Covered:

  • In-vitro Testing
  • In-silico Modeling
  • In-vivo Testing

Test Types Covered:

  • Phototoxicity Tests
  • Skin Irritation Tests
  • Skin Sensitization Tests
  • Skin Corrosion Tests
  • Other Test Types

End Users Covered:

  • Cosmetics and Personal Care Products Industry
  • Chemical Industry
  • Healthcare Industry
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Dermal Toxicity Testing Market, By Type

  • 5.1 Introduction
  • 5.2 Product
  • 5.3 Services
    • 5.3.1 Inhouse Services
    • 5.3.2 Outsource Services
  • 5.4 Other Types

6 Global Dermal Toxicity Testing Market, By Testing Method

  • 6.1 Introduction
  • 6.2 In-vitro Testing
  • 6.3 In-silico Modeling
  • 6.4 In-vivo testing

7 Global Dermal Toxicity Testing Market, By Test Type

  • 7.1 Introduction
  • 7.2 Phototoxicity Tests
  • 7.3 Skin Irritation Tests
  • 7.4 Skin Sensitization Tests
  • 7.5 Skin Corrosion Tests
  • 7.6 Other Test Types

8 Global Dermal Toxicity Testing Market, By End User

  • 8.1 Introduction
  • 8.2 Cosmetics and Personal Care Products Industry
  • 8.3 Chemical Industry
  • 8.4 Healthcare Industry
  • 8.5 Other End Users

9 Global Dermal Toxicity Testing Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 SGS S.A
  • 11.2 Bio-Rad Laboratories Inc.
  • 11.3 Charles River Laboratories International, Inc.
  • 11.4 Catalent, Inc.
  • 11.5 Eurofins Scientific Inc
  • 11.6 Thermo Fisher Scientific, Inc.
  • 11.7 Covance, Inc
  • 11.8 GE Healthcare
  • 11.9 Qiagen N.V.
  • 11.10 Merck KgaA
  • 11.11 Intertek Group
  • 11.12 MatTek Corporation
  • 11.13 Evotec

List of Tables

  • Table 1 Global Dermal Toxicity Testing Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Dermal Toxicity Testing Market Outlook, By Type (2023-2034) ($MN)
  • Table 3 Global Dermal Toxicity Testing Market Outlook, By Product (2023-2034) ($MN)
  • Table 4 Global Dermal Toxicity Testing Market Outlook, By Services (2023-2034) ($MN)
  • Table 5 Global Dermal Toxicity Testing Market Outlook, By Inhouse Services (2023-2034) ($MN)
  • Table 6 Global Dermal Toxicity Testing Market Outlook, By Outsource Services (2023-2034) ($MN)
  • Table 7 Global Dermal Toxicity Testing Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 8 Global Dermal Toxicity Testing Market Outlook, By Testing Method (2023-2034) ($MN)
  • Table 9 Global Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2023-2034) ($MN)
  • Table 10 Global Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2023-2034) ($MN)
  • Table 11 Global Dermal Toxicity Testing Market Outlook, By In-vivo testing (2023-2034) ($MN)
  • Table 12 Global Dermal Toxicity Testing Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 13 Global Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2023-2034) ($MN)
  • Table 14 Global Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2023-2034) ($MN)
  • Table 15 Global Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2023-2034) ($MN)
  • Table 16 Global Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2023-2034) ($MN)
  • Table 17 Global Dermal Toxicity Testing Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 18 Global Dermal Toxicity Testing Market Outlook, By End User (2023-2034) ($MN)
  • Table 19 Global Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2023-2034) ($MN)
  • Table 20 Global Dermal Toxicity Testing Market Outlook, By Chemical Industry (2023-2034) ($MN)
  • Table 21 Global Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2023-2034) ($MN)
  • Table 22 Global Dermal Toxicity Testing Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 23 North America Dermal Toxicity Testing Market Outlook, By Country (2023-2034) ($MN)
  • Table 24 North America Dermal Toxicity Testing Market Outlook, By Type (2023-2034) ($MN)
  • Table 25 North America Dermal Toxicity Testing Market Outlook, By Product (2023-2034) ($MN)
  • Table 26 North America Dermal Toxicity Testing Market Outlook, By Services (2023-2034) ($MN)
  • Table 27 North America Dermal Toxicity Testing Market Outlook, By Inhouse Services (2023-2034) ($MN)
  • Table 28 North America Dermal Toxicity Testing Market Outlook, By Outsource Services (2023-2034) ($MN)
  • Table 29 North America Dermal Toxicity Testing Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 30 North America Dermal Toxicity Testing Market Outlook, By Testing Method (2023-2034) ($MN)
  • Table 31 North America Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2023-2034) ($MN)
  • Table 32 North America Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2023-2034) ($MN)
  • Table 33 North America Dermal Toxicity Testing Market Outlook, By In-vivo testing (2023-2034) ($MN)
  • Table 34 North America Dermal Toxicity Testing Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 35 North America Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2023-2034) ($MN)
  • Table 36 North America Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2023-2034) ($MN)
  • Table 37 North America Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2023-2034) ($MN)
  • Table 38 North America Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2023-2034) ($MN)
  • Table 39 North America Dermal Toxicity Testing Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 40 North America Dermal Toxicity Testing Market Outlook, By End User (2023-2034) ($MN)
  • Table 41 North America Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2023-2034) ($MN)
  • Table 42 North America Dermal Toxicity Testing Market Outlook, By Chemical Industry (2023-2034) ($MN)
  • Table 43 North America Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2023-2034) ($MN)
  • Table 44 North America Dermal Toxicity Testing Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 45 Europe Dermal Toxicity Testing Market Outlook, By Country (2023-2034) ($MN)
  • Table 46 Europe Dermal Toxicity Testing Market Outlook, By Type (2023-2034) ($MN)
  • Table 47 Europe Dermal Toxicity Testing Market Outlook, By Product (2023-2034) ($MN)
  • Table 48 Europe Dermal Toxicity Testing Market Outlook, By Services (2023-2034) ($MN)
  • Table 49 Europe Dermal Toxicity Testing Market Outlook, By Inhouse Services (2023-2034) ($MN)
  • Table 50 Europe Dermal Toxicity Testing Market Outlook, By Outsource Services (2023-2034) ($MN)
  • Table 51 Europe Dermal Toxicity Testing Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 52 Europe Dermal Toxicity Testing Market Outlook, By Testing Method (2023-2034) ($MN)
  • Table 53 Europe Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2023-2034) ($MN)
  • Table 54 Europe Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2023-2034) ($MN)
  • Table 55 Europe Dermal Toxicity Testing Market Outlook, By In-vivo testing (2023-2034) ($MN)
  • Table 56 Europe Dermal Toxicity Testing Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 57 Europe Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2023-2034) ($MN)
  • Table 58 Europe Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2023-2034) ($MN)
  • Table 59 Europe Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2023-2034) ($MN)
  • Table 60 Europe Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2023-2034) ($MN)
  • Table 61 Europe Dermal Toxicity Testing Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 62 Europe Dermal Toxicity Testing Market Outlook, By End User (2023-2034) ($MN)
  • Table 63 Europe Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2023-2034) ($MN)
  • Table 64 Europe Dermal Toxicity Testing Market Outlook, By Chemical Industry (2023-2034) ($MN)
  • Table 65 Europe Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2023-2034) ($MN)
  • Table 66 Europe Dermal Toxicity Testing Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 67 Asia Pacific Dermal Toxicity Testing Market Outlook, By Country (2023-2034) ($MN)
  • Table 68 Asia Pacific Dermal Toxicity Testing Market Outlook, By Type (2023-2034) ($MN)
  • Table 69 Asia Pacific Dermal Toxicity Testing Market Outlook, By Product (2023-2034) ($MN)
  • Table 70 Asia Pacific Dermal Toxicity Testing Market Outlook, By Services (2023-2034) ($MN)
  • Table 71 Asia Pacific Dermal Toxicity Testing Market Outlook, By Inhouse Services (2023-2034) ($MN)
  • Table 72 Asia Pacific Dermal Toxicity Testing Market Outlook, By Outsource Services (2023-2034) ($MN)
  • Table 73 Asia Pacific Dermal Toxicity Testing Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 74 Asia Pacific Dermal Toxicity Testing Market Outlook, By Testing Method (2023-2034) ($MN)
  • Table 75 Asia Pacific Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2023-2034) ($MN)
  • Table 76 Asia Pacific Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2023-2034) ($MN)
  • Table 77 Asia Pacific Dermal Toxicity Testing Market Outlook, By In-vivo testing (2023-2034) ($MN)
  • Table 78 Asia Pacific Dermal Toxicity Testing Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 79 Asia Pacific Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2023-2034) ($MN)
  • Table 80 Asia Pacific Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2023-2034) ($MN)
  • Table 81 Asia Pacific Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2023-2034) ($MN)
  • Table 82 Asia Pacific Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2023-2034) ($MN)
  • Table 83 Asia Pacific Dermal Toxicity Testing Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 84 Asia Pacific Dermal Toxicity Testing Market Outlook, By End User (2023-2034) ($MN)
  • Table 85 Asia Pacific Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2023-2034) ($MN)
  • Table 86 Asia Pacific Dermal Toxicity Testing Market Outlook, By Chemical Industry (2023-2034) ($MN)
  • Table 87 Asia Pacific Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2023-2034) ($MN)
  • Table 88 Asia Pacific Dermal Toxicity Testing Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 89 South America Dermal Toxicity Testing Market Outlook, By Country (2023-2034) ($MN)
  • Table 90 South America Dermal Toxicity Testing Market Outlook, By Type (2023-2034) ($MN)
  • Table 91 South America Dermal Toxicity Testing Market Outlook, By Product (2023-2034) ($MN)
  • Table 92 South America Dermal Toxicity Testing Market Outlook, By Services (2023-2034) ($MN)
  • Table 93 South America Dermal Toxicity Testing Market Outlook, By Inhouse Services (2023-2034) ($MN)
  • Table 94 South America Dermal Toxicity Testing Market Outlook, By Outsource Services (2023-2034) ($MN)
  • Table 95 South America Dermal Toxicity Testing Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 96 South America Dermal Toxicity Testing Market Outlook, By Testing Method (2023-2034) ($MN)
  • Table 97 South America Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2023-2034) ($MN)
  • Table 98 South America Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2023-2034) ($MN)
  • Table 99 South America Dermal Toxicity Testing Market Outlook, By In-vivo testing (2023-2034) ($MN)
  • Table 100 South America Dermal Toxicity Testing Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 101 South America Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2023-2034) ($MN)
  • Table 102 South America Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2023-2034) ($MN)
  • Table 103 South America Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2023-2034) ($MN)
  • Table 104 South America Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2023-2034) ($MN)
  • Table 105 South America Dermal Toxicity Testing Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 106 South America Dermal Toxicity Testing Market Outlook, By End User (2023-2034) ($MN)
  • Table 107 South America Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2023-2034) ($MN)
  • Table 108 South America Dermal Toxicity Testing Market Outlook, By Chemical Industry (2023-2034) ($MN)
  • Table 109 South America Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2023-2034) ($MN)
  • Table 110 South America Dermal Toxicity Testing Market Outlook, By Other End Users (2023-2034) ($MN)
  • 111 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Country (2023-2034) ($MN)
  • 112 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Type (2023-2034) ($MN)
  • 113 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Product (2023-2034) ($MN)
  • 114 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Services (2023-2034) ($MN)
  • 115 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Inhouse Services (2023-2034) ($MN)
  • 116 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Outsource Services (2023-2034) ($MN)
  • 117 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Other Types (2023-2034) ($MN)
  • 118 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Testing Method (2023-2034) ($MN)
  • 119 Middle East & Africa Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2023-2034) ($MN)
  • 120 Middle East & Africa Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2023-2034) ($MN)
  • 121 Middle East & Africa Dermal Toxicity Testing Market Outlook, By In-vivo testing (2023-2034) ($MN)
  • 122 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Test Type (2023-2034) ($MN)
  • 123 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2023-2034) ($MN)
  • 124 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2023-2034) ($MN)
  • 125 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2023-2034) ($MN)
  • 126 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2023-2034) ($MN)
  • 127 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Other Test Types (2023-2034) ($MN)
  • 128 Middle East & Africa Dermal Toxicity Testing Market Outlook, By End User (2023-2034) ($MN)
  • 129 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2023-2034) ($MN)
  • 130 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Chemical Industry (2023-2034) ($MN)
  • 131 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2023-2034) ($MN)
  • 132 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Other End Users (2023-2034) ($MN)